155 related articles for article (PubMed ID: 34231328)
1. Evidence for abnormal linkage between urine oxalate and citrate excretion in human kidney stone formers.
Prochaska ML; Moe OW; Asplin JR; Coe FL; Worcester EM
Physiol Rep; 2021 Jul; 9(13):e14943. PubMed ID: 34231328
[TBL] [Abstract][Full Text] [Related]
2. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
3. Biochemical risk factors for stone formation in a Scottish paediatric hospital population.
MacDougall L; Taheri S; Crofton P
Ann Clin Biochem; 2010 Mar; 47(Pt 2):125-30. PubMed ID: 20144971
[TBL] [Abstract][Full Text] [Related]
4. Determinants of urinary excretion of Tamm-Horsfall protein in non-selected kidney stone formers and healthy subjects.
Glauser A; Hochreiter W; Jaeger P; Hess B
Nephrol Dial Transplant; 2000 Oct; 15(10):1580-7. PubMed ID: 11007825
[TBL] [Abstract][Full Text] [Related]
5. Body size and 24-hour urine composition.
Taylor EN; Curhan GC
Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
[TBL] [Abstract][Full Text] [Related]
6. Effect of citrate on the urinary excretion of calcium and oxalate: relevance to calcium oxalate nephrolithiasis.
Cowley DM; McWhinney BC; Brown JM; Chalmers AH
Clin Chem; 1989 Jan; 35(1):23-8. PubMed ID: 2910576
[TBL] [Abstract][Full Text] [Related]
7. Genetic and dietary factors in urinary citrate excretion.
Shah O; Assimos DG; Holmes RP
J Endourol; 2005 Mar; 19(2):177-82. PubMed ID: 15798414
[TBL] [Abstract][Full Text] [Related]
8. Excretion of urine extracellular vesicles bearing markers of activated immune cells and calcium/phosphorus physiology differ between calcium kidney stone formers and non-stone formers.
Zhang J; Kumar S; Jayachandran M; Herrera Hernandez LP; Wang S; Wilson EM; Lieske JC
BMC Nephrol; 2021 Jun; 22(1):204. PubMed ID: 34074247
[TBL] [Abstract][Full Text] [Related]
9. Different dietary calcium intake and relative supersaturation of calcium oxalate in the urine of patients forming renal stones.
Messa P; Marangella M; Paganin L; Codardini M; Cruciatti A; Turrin D; Filiberto Z; Mioni G
Clin Sci (Lond); 1997 Sep; 93(3):257-63. PubMed ID: 9337641
[TBL] [Abstract][Full Text] [Related]
10. Urinary saturation and risk factors for calcium oxalate stone disease based on spot and 24-hour urine specimens.
Ogawa Y; Yonou H; Hokama S; Oda M; Morozumi M; Sugaya K
Front Biosci; 2003 Sep; 8():a167-76. PubMed ID: 12957883
[TBL] [Abstract][Full Text] [Related]
11. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
[TBL] [Abstract][Full Text] [Related]
12. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
[TBL] [Abstract][Full Text] [Related]
13. Preservation of urine samples for metabolic evaluation of stone-forming patients.
Ferraz RR; Baxmann AC; Ferreira LG; Nishiura JL; Siliano PR; Gomes SA; Moreira SR; Heilberg IP
Urol Res; 2006 Oct; 34(5):329-37. PubMed ID: 16896690
[TBL] [Abstract][Full Text] [Related]
14. SLC26A6 and NaDC-1 transporters interact to regulate oxalate and citrate homeostasis.
Ohana E; Shcheynikov N; Moe OW; Muallem S
J Am Soc Nephrol; 2013 Oct; 24(10):1617-26. PubMed ID: 23833257
[TBL] [Abstract][Full Text] [Related]
15. [Citrate and kidney stones].
Osther PJ
Ugeskr Laeger; 1993 Nov; 155(47):3835-9. PubMed ID: 8256384
[TBL] [Abstract][Full Text] [Related]
16. Chemical factors important to calcium nephrolithiasis: evidence for impaired hydroxycarboxylic acid absorption causing hyperoxaluria.
Cowley DM; McWhinney BC; Brown JM; Chalmers AH
Clin Chem; 1987 Feb; 33(2 Pt 1):243-7. PubMed ID: 3802507
[TBL] [Abstract][Full Text] [Related]
17. Glycine suppresses kidney calcium oxalate crystal depositions via regulating urinary excretions of oxalate and citrate.
Lan Y; Zhu W; Duan X; Deng T; Li S; Liu Y; Yang Z; Wen Y; Luo L; Zhao S; Wang J; Zhao Z; Wu W; Zeng G
J Cell Physiol; 2021 Oct; 236(10):6824-6835. PubMed ID: 33772775
[TBL] [Abstract][Full Text] [Related]
18. Urinary Lithogenic Risk Profile in ADPKD Patients Treated with Tolvaptan.
Bargagli M; Dhayat NA; Anderegg M; Semmo M; Huynh-Do U; Vogt B; Ferraro PM; Fuster DG
Clin J Am Soc Nephrol; 2020 Jul; 15(7):1007-1014. PubMed ID: 32527945
[TBL] [Abstract][Full Text] [Related]
19. Estimating 24-hour urinary excretion using spot urine measurements in kidney stone formers.
Ferraro PM; Lopez F; Petrarulo M; Barbarini S; Curhan GC; Marangella M; Taylor EN
Nephrol Dial Transplant; 2022 Oct; 37(11):2171-2179. PubMed ID: 35146503
[TBL] [Abstract][Full Text] [Related]
20. Association between vitamin D receptor gene polymorphisms and tubular citrate handling in calcium nephrolithiasis.
Mossetti G; Vuotto P; Rendina D; Numis FG; Viceconti R; Giordano F; Cioffi M; Scopacasa F; Nunziata V
J Intern Med; 2003 Feb; 253(2):194-200. PubMed ID: 12542560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
